# Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study

> **NCT07664748** · NA · NOT_YET_RECRUITING · sponsor: **Niguarda Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** AVATAR-SC
- **DRUG:** Levosimendan

## Key facts

- **NCT ID:** NCT07664748
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2027-05-15
- **Final completion:** 2028-05-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07664748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07664748, "Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07664748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*